Form 4 for TMCI TREACE MEDICAL CONCEPTS, INC.
Accepted 2023-03-10 00:00:00 ET · period of report 2023-03-09 · accession 0001209191-23-018043 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-10 | 2023-03-09 | TMCI | Owens Daniel E. | CHRO | S - Sale | $24.41 | -411 | 10.3K | -4% | -$10.0K |
| D | 2023-03-10 | 2023-03-10 | TMCI | Owens Daniel E. | CHRO | A - Grant | $0.00 | +20.6K | 30.9K | +200% | $0 |
| D | 2023-03-10 | 2023-03-10 | TMCI | Owens Daniel E. | CHRO | A - Grant | $0.00 | +46.8K | 46.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-09 | S | D | 411 | $24.41 | 10,289 | D | — | — | (F1) The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. (F2) Includes 5,025 RSUs. |
| 2 | Common | Common Stock | 2023-03-10 | A | A | 20,625 | $0.00 | 30,914 | D | — | — | (F3) Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date. (F4) Includes 25,650 RSUs. |
| 3 | Derivative | Stock Option Right to Buy | 2023-03-10 | A | A | 46,750 | $0.00 | 46,750 | D | $24.07 · — to 2033-03-10 | 46,750 Stock Option Right to Buy | (F5) The stock option will vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date. |